Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha (Q33867947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1 reference

1 reference

Maria E Sobaniec-Lotowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Maciej Kaczmarski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Dariusz-Marek Lebensztejn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Michael Voelker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Detlef Schuppan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

3338-3343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

Histological outcome of chronic hepatitis B in children treated with interferon alpha

28 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Evaluation of liver fibrosis: a concise review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Management of hepatitis B: 2000--summary of a workshop

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Long term effect of alpha interferon in children with chronic hepatitis B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

The role of liver biopsy in hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Matrix turnover in fibrogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Clinical use of serum markers of fibrosis in chronic hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Serum assays for liver fibrosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Chronic hepatitis. An update on terminology and reporting.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Scavenger functions of the liver endothelial cell

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

A 21-year experience with major hemorrhage after percutaneous liver biopsy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087863

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

29 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I21.3338

Hepatic expression of viral antigens, hepatocytic proliferative activity and histologic changes in liver biopsies of children with chronic hepatitis B after interferon-alpha therapy

21 January 2018

1 reference

12 December 2020

Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia

1 reference

12 December 2020

Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1 analyzer

1 reference

12 December 2020

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis

1 reference

12 December 2020

[Diagnostic value of five serum markers for liver fibrosis]

1 reference

12 December 2020

Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia

1 reference

12 December 2020

Biopsy or Biomarkers: Is There a Gold Standard for Diagnosis of Liver Fibrosis?

1 reference

12 December 2020

Serum type III procollagen peptide as a non-invasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and alpha 1 antitrypsin deficiency

1 reference

12 December 2020

Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders

1 reference

12 December 2020

A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B

1 reference

12 December 2020

Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I21.3338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

PubMed publication ID

16733849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16733849%20AND%20SRC:MED&resulttype=core&format=json